This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blusch, J. H.
Right arrow Articles by von der Helm, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blusch, J. H.
Right arrow Articles by von der Helm, K.

 Previous Article  |  Next Article 

Journal of Virology, August 2002, p. 7913-7917, Vol. 76, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.15.7913-7917.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Molecular and Enzymatic Characterization of the Porcine Endogenous Retrovirus Protease

Jürgen H. Blusch,,{dagger} Sigrid Seelmeir, and Klaus von der Helm*

Max-von-Pettenkofer Institut, Ludwig-Maximilians-Universität München, D-80336 Munich, Germany

Received 19 October 2001/ Accepted 22 April 2002

The protease of the porcine endogenous retrovirus (PERV) subtypes A/B and C was recombinantly expressed in Escherichia coli as proteolytically active enzyme and characterized. The PERV Gag precursor was also recombinantly produced and used as the substrate in an in vitro enzyme assay in parallel with synthetic nonapeptide substrates designed according to cleavage site sequences identified in the PERV Gag precursor. The proteases of all PERV subtypes consist of 127 amino acid residues with an Mr of 14,000 as revealed by determining the protease N and C termini. The PERV proteases have a high specificity for PERV substrates and do not cleave human immunodeficiency virus (HIV)-specific substrates, nor are they inhibited by specific HIV protease inhibitors. Among the known retroviral proteases, the PERV proteases resemble most closely the protease of the murine leukemia retrovirus.

* Corresponding author. Mailing address: Max-von-Pettenkofer Institut, Ludwig-Maximilians-Universität München, Pettekonferstr. 9A, D-80336 Munich, Germany. Phone and fax: 089-5160-5257. E-mail: kvdh{at}mvp.med.uni-muenchen.de.

{dagger} Present address: Novartis Pharma AG, BTD Bioanalytics, Basel, Switzerland.

Journal of Virology, August 2002, p. 7913-7917, Vol. 76, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.15.7913-7917.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»